Jonathan Hopper - Feb 22, 2024 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Chief Medical Officer
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Stock symbol
VCEL
Transactions as of
Feb 22, 2024
Transactions value $
$0
Form type
4
Date filed
2/26/2024, 04:05 PM
Previous filing
Feb 22, 2024
Next filing
May 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Stock Option (Right to Buy) Award $0 +30K $0.00 30K Feb 22, 2024 Common Stock 30K $48.31 Direct F1
transaction VCEL Restricted Stock Unit Award $0 +12K $0.00 12K Feb 22, 2024 Common Stock 12K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options shall begin vesting on February 22, 2024 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F2 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3 These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 22, 2025. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively.
F4 No expiration date for this type of award.